Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial

NCT00701740 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Photoaging
Epidermal p53 Expression

Interventions

DRUG: oral isotretinoin and Mexoryl SX / XL
DRUG: Mexoryl XL / SX

Sponsor

Federal University of São Paulo